Astrana Health (NASDAQ:ASTH – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $1.28 to $1.52 for the period, compared to the consensus EPS estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.
Astrana Health Trading Down 1.0 %
NASDAQ:ASTH traded down $0.39 during mid-day trading on Tuesday, hitting $37.93. 125,521 shares of the company’s stock traded hands, compared to its average volume of 153,978. The company has a market capitalization of $2.13 billion, a price-to-earnings ratio of 28.74, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The firm’s 50 day moving average price is $40.47. The company has a quick ratio of 2.11, a current ratio of 2.11 and a debt-to-equity ratio of 0.42. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71.
Astrana Health (NASDAQ:ASTH – Get Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.09. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The company had revenue of $353.00 million for the quarter, compared to the consensus estimate of $341.17 million. During the same quarter in the previous year, the firm posted $0.02 EPS. The business’s revenue was up 20.0% compared to the same quarter last year. As a group, equities research analysts expect that Astrana Health will post 1.65 earnings per share for the current year.
Wall Street Analyst Weigh In
View Our Latest Analysis on ASTH
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
- Five stocks we like better than Astrana Health
- What is a Secondary Public Offering? What Investors Need to Know
- Garmin Navigates to New Highs Driven By Wearables Trend
- Why Are Stock Sectors Important to Successful Investing?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.